SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Rigel Pharmaceuticals, Inc. (RIGL) -- Ignore unavailable to you. Want to Upgrade?


To: mopgcw who wrote (385)10/28/2008 11:37:34 AM
From: scaram(o)uche  Read Replies (1) | Respond to of 566
 
I guess the perception is that small molecules don't look any better than competitive biologicals and that Gower can't deliver a partner. CS still believes otherwise (thanks!).

There's a Dow Jones headline out... "Rigel shares plunge on arthritis drug study". It could have read "Rigel shares plunge on arthritis drug study showing marked efficacy".